Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells

Breast Cancer Research and Treatment

Volumn 123, Issue 1, 2010, Pages 87-96

  Ignatov, Atanas ^a   Ignatov, Tanja ^a   Roessner, Albert ^a   Costa, Serban Dan ^a   Kalinski, Thomas ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Breast cancer; Estrogen; GPR30; Tamoxifen resistance

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; 5' NUCLEOTIDASE; ANTISENSE OLIGONUCLEOTIDE; CALNEXIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; G PROTEIN COUPLED RECEPTOR 30; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; TAMOXIFEN; G PROTEIN COUPLED RECEPTOR; GPER PROTEIN, HUMAN; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ARTICLE; BREAST CANCER; CELL COUNT; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 7; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; BREAST TUMOR; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; GENE EXPRESSION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION; HUMANS; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, G-PROTEIN-COUPLED; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SIGNAL TRANSDUCTION; TAMOXIFEN; RECEPTORS, ESTROGEN;

EID: 77955771545     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0624-6     Document Type: Article

References (33)

1. Tamoxifen for early breast cancer: an overview of the randomised trials 1998 Early breast cancer trialists' collaborative group Lancet 351 1451 1467 10.1016/S0140-6736(97)11423-4 (Pubitemid 28227036)
2. TJ Powles S Ashley A Tidy IE Smith M Dowsett 2007 Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial J Natl Cancer Inst 99 283 290 10.1093/jnci/djk050 1:CAS:528:DC%2BD2sXjsVeitrg%3D 17312305 (Pubitemid 47073491)
3. J Kurebayashi 2005 Resistance to endocrine therapy in breast cancer Cancer Chemother Pharmacol 56 Suppl 1 39 46 10.1007/s00280-005-0099-z 16273353 (Pubitemid 41755690)
4. RI Nicholson RA McClelland P Finlay CL Eaton WJ Gullick AR Dixon JF Robertson IO Ellis RW Blamey 1993 Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity Eur J Cancer 29A 1018 1023 10.1016/S0959-8049(05)80215-1 1:STN:280: DyaK3s3ntVyjtw%3D%3D 8098946
5. C Wright S Nicholson B Angus JR Sainsbury J Farndon J Cairns AL Harris CH Horne 1992 Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer Br J Cancer 65 118 121 1:STN:280:DyaK387is1Crug%3D%3D 1346366
6. IR Hutcheson JM Knowlden TA Madden D Barrow JM Gee AE Wakeling RI Nicholson 2003 Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells Breast Cancer Res Treat 81 81 93 10.1023/A:1025484908380 1:CAS:528:DC%2BD3sXms1Gjs7o%3D 14531500 (Pubitemid 37108443)
7. JM Rae MD Johnson 2005 What does an orphan G-protein-coupled receptor have to do with estrogen? Breast Cancer Res 7 243 244 10.1186/bcr1330 1:CAS:528:DC%2BD2MXht1WmsrrF 16280047 (Pubitemid 41830160)
8. ER Prossnitz TI Oprea LA Sklar JB Arterburn 2008 The ins and outs of GPR30: a transmembrane estrogen receptor J Steroid Biochem Mol Biol 109 350 353 10.1016/j.jsbmb.2008.03.006 1:CAS:528:DC%2BD1cXmsVeitb0%3D 18406603
9. EJ Filardo 2002 Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer J Steroid Biochem Mol Biol 80 231 238 10.1016/S0960-0760(01)00190-X 1:CAS:528:DC%2BD38XhvVCiur8%3D 11897506 (Pubitemid 34233742)
10. 2+ release by activating the sphingosine-kinase pathway Biochem Biophys Res Commun 311 329 336 10.1016/j.bbrc.2003.10.006 1:CAS:528:DC%2BD3sXosFSntL8%3D 14592418 (Pubitemid 37340081)
11. 2+ mobilization and inositol trisphosphate (IP3) formation in cells transfected with G protein-coupled receptor 75 Br J Pharmacol 149 490 497 10.1038/sj.bjp.0706909 1:CAS:528:DC%2BD28XhtFeru7vI 17001303 (Pubitemid 44658509)
12. NJ Jordan JM Gee D Barrow AE Wakeling RI Nicholson 2004 Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells Breast Cancer Res Treat 87 167 180 10.1023/B:BREA.0000041623.21338.47 1:CAS:528:DC%2BD2cXnsFOqtLc%3D 15377841 (Pubitemid 39237793)
13. CK Osborne J Shou S Massarweh R Schiff 2005 Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer Clin Cancer Res 11 865s 870s 1:CAS:528: DC%2BD2MXislWgu7k%3D 15701879 (Pubitemid 40111098)
14. CM Revankar DF Cimino LA Sklar JB Arterburn ER Prossnitz 2005 A transmembrane intracellular estrogen receptor mediates rapid cell signaling Science 307 1625 1630 10.1126/science.1106943 1:CAS:528:DC%2BD2MXitV2is7c%3D 15705806 (Pubitemid 40354745)
15. P Thomas Y Pang EJ Filardo J Dong 2005 Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells Endocrinology 146 624 632 10.1210/en.2004-1064 1:CAS:528:DC%2BD2MXotlWitw%3D%3D 15539556 (Pubitemid 40129818)
16. EJ Filardo JA Quinn KI Bland AR Frackelton Jr 2000 Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF Mol Endocrinol 14 1649 1660 10.1210/me.14.10.1649 1:CAS:528:DC%2BD3cXntVaksLk%3D 11043579
17. M Maggiolini A Vivacqua G Fasanella AG Recchia D Sisci V Pezzi D Montanaro AM Musti D Picard S Ando 2004 The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17 beta-estradiol and phytoestrogens in breast cancer cells J Biol Chem 279 27008 27016 10.1074/jbc.M403588200 1:CAS:528:DC%2BD2cXkvFGnsrc%3D 15090535 (Pubitemid 38812536)
18. A Vivacqua D Bonofiglio AG Recchia AM Musti D Picard S Ando M Maggiolini 2006 The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17 beta-estradiol and hydroxytamoxifen in endometrial cancer cells Mol Endocrinol 20 631 646 10.1210/me.2005-0280 1:CAS:528:DC%2BD28Xit1Snsb4%3D 16239258 (Pubitemid 43291214)
19. A Vivacqua D Bonofiglio L Albanito A Madeo V Rago A Carpino AM Musti D Picard S Ando M Maggiolini 2006 17 beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30 Mol Pharmacol 70 1414 1423 10.1124/mol.106. 026344 1:CAS:528:DC%2BD28XhtVOjtL7J 16835357 (Pubitemid 44435994)
20. ER Levin 2009 G protein-coupled receptor 30: estrogen receptor or collaborator? Endocrinology 150 1563 1565 10.1210/en.2008-1759 1:CAS:528:DC%2BD1MXktVWmurg%3D 19307418
21. K Leblanc E Sexton S Parent G Belanger MC Dery V Boucher E Asselin 2007 Effects of 4-hydroxytamoxifen, raloxifene and ICI 182 780 on survival of uterine cancer cell lines in the presence and absence of exogenous estrogens Int J Oncol 30 477 487 1:CAS:528:DC%2BD2sXhvFyru7o%3D 17203231
22. P Fan W Yue JP Wang S Aiyar Y Li TH Kim RJ Santen 2009 Mechanisms of resistance to structurally diverse antiestrogens differ under premenopausal and postmenopausal conditions: evidence from in vitro breast cancer cell models Endocrinology 150 2036 2045 10.1210/en.2008-1195 1:CAS:528:DC%2BD1MXlsFCjt7s%3D 19179445
23. PL Bedard OC Freedman A Howell M Clemons 2008 Overcoming endocrine resistance in breast cancer: are signal transduction inhibitors the answer? Breast Cancer Res Treat 108 307 317 10.1007/s10549-007-9606-8 1:CAS:528:DC%2BD1cXjsFGisb4%3D 18351454 (Pubitemid 351431070)
24. ER Levin 2003 Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor Mol Endocrinol 17 309 317 10.1210/me.2002-0368 1:CAS:528:DC%2BD3sXitlOitLY%3D 12554774 (Pubitemid 36315626)
25. EJ Filardo CT Graeber JA Quinn MB Resnick D Giri RA DeLellis MM Steinhoff E Sabo 2006 Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression Clin Cancer Res 12 6359 6366 10.1158/1078-0432.CCR-06-0860 1:CAS:528:DC%2BD28XhtFKitb7M 17085646 (Pubitemid 44799705)
26. Vivacqua A, Lappano R, De Marco P, Sisci D, Aquila S, De Amicis F, Fuqua SA, Ando S, Maggiolini M (2009) G Protein-coupled receptor 30 expression is up-regulated by EGF and TGFα in estrogen receptor α-positive cancer cells. Mol Endocrinol. doi: 10.1210/me.2009-0120
27. P Fan J Wang RJ Santen W Yue 2007 Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells Cancer Res 67 1352 1360 10.1158/0008-5472.CAN-06-1020 1:CAS:528:DC%2BD2sXht1ynt78%3D 17283173
28. JM Gee ME Harper IR Hutcheson TA Madden D Barrow JM Knowlden RA McClelland N Jordan AE Wakeling RI Nicholson 2003 The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro Endocrinology 144 5105 5117 10.1210/en.2003-0705 1:CAS:528:DC%2BD3sXosleqsr0%3D 12960029 (Pubitemid 37378426)
29. J Shou S Massarweh CK Osborne AE Wakeling S Ali H Weiss R Schiff 2004 Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer J Natl Cancer Inst 96 926 935 10.1093/jnci/djh166 1:CAS:528:DC%2BD2cXltVWmtLY%3D 15199112
30. MC Gutierrez S Detre S Johnston SK Mohsin J Shou DC Allred R Schiff CK Osborne M Dowsett 2005 Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase J Clin Oncol 23 2469 2476 10.1200/JCO.2005.01.172 1:CAS:528: DC%2BD2MXjvVyktL8%3D 15753463 (Pubitemid 47050837)
31. M Razandi A Pedram ST Park ER Levin 2003 Proximal events in signaling by plasma membrane estrogen receptors J Biol Chem 278 2701 2712 10.1074/jbc.M205692200 1:CAS:528:DC%2BD3sXksFaktw%3D%3D 12421825 (Pubitemid 36801351)
32. A deFazio YE Chiew RL Sini PW Janes RL Sutherland 2000 Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines Int J Cancer 87 487 498 10.1002/1097-0215(20000815)87:4<487::AID-IJC5>3.0. CO;2-J 1:CAS:528:DC%2BD3cXlvVynu7c%3D 10918187
33. MA Wilson SA Chrysogelos 2002 Identification and characterization of a negative regulatory element within the epidermal growth factor receptor gene first intron in hormone-dependent breast cancer cells J Cell Biochem 85 601 614 10.1002/jcb.10168 1:CAS:528:DC%2BD38XjsFGms7o%3D 11968000 (Pubitemid 34465140)